Evaluation of cytokines as adjuvants of infectious bovine keratoconjunctivitis vaccines

被引:9
|
作者
di Girolamo, Fabio A. [1 ,2 ,3 ,4 ]
Jorge Sabatini, Diego [4 ]
Fasan, Raul A. [4 ]
Echegoyen, Maia [4 ]
Vela, Mauro [4 ]
Pereira, Claudio A. [2 ,3 ]
Maure, Pablo [1 ]
机构
[1] CIV, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Inst Invest Med A Lanari IDIM, RA-1033 Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Buenos Aires, DF, Argentina
[4] Pontificia Univ Catolica Argentina UCA, Fac Ciencias Agr, Buenos Aires, DF, Argentina
关键词
Infectious bovine keratoconjunctivitis; Moraxella bovis; Cytokines; MORAXELLA-BOVIS; INTERFERON;
D O I
10.1016/j.vetimm.2011.12.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this work two cytokines were used in combination with inactivated bacteria (bacterin) to test the bovine conjuctival immune response to the pathogen Moraxella bovis, the causative agent of Infectious bovine keratoconjunctivitis (IBK). Treatments using the bacterin vaccine combined with interleukin-2 and interferon-alpha as adjuvants (Group A), the bacterin vaccine only (Group B), and controls without treatment (Group C), were applied by ocular spraying to evaluate the local immune response in the corneal structure of cattle experimentally infected with M. bovis. Six weeks after infection, 14 out of a total of 34 animals presented different corneal lesions; 9 corresponding to the control group C, 4 to the group B and only one to the group A. According to the clinical manifestations, a numeric score was calculated. Control animals presented the highest score value (12 points), followed by group B (7.5 points) and group A (1 point). These results suggest that the addition of cytokines to M. bovis treatments can reduce not only eye injuries caused by IBK but also the number of diseased animals. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:563 / 566
页数:4
相关论文
共 50 条
  • [1] EFFECTIVENESS OF 2 COMMERCIAL INFECTIOUS BOVINE KERATOCONJUNCTIVITIS VACCINES
    SMITH, PC
    BLANKENSHIP, T
    HOOVER, TR
    POWE, T
    WRIGHT, JC
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 1990, 51 (07) : 1147 - 1150
  • [2] BOVINE INFECTIOUS KERATOCONJUNCTIVITIS
    FLEMING, GA
    [J]. VETERINARY RECORD, 1975, 97 (24) : 486 - 486
  • [3] INFECTIOUS BOVINE KERATOCONJUNCTIVITIS
    COOPER, GM
    [J]. VETERINARY RECORD, 1985, 117 (15) : 394 - 394
  • [4] BOVINE INFECTIOUS KERATOCONJUNCTIVITIS
    DALTON, JR
    [J]. VETERINARY RECORD, 1976, 98 (01) : 17 - 18
  • [5] INFECTIOUS BOVINE KERATOCONJUNCTIVITIS
    AIKMAN, JG
    SELMAN, IE
    ALLAN, EM
    [J]. VETERINARY RECORD, 1985, 117 (22) : 591 - 591
  • [6] INFECTIOUS BOVINE KERATOCONJUNCTIVITIS
    TAYLOR, GB
    [J]. VETERINARY RECORD, 1985, 117 (16) : 420 - 420
  • [7] BOVINE INFECTIOUS KERATOCONJUNCTIVITIS
    CRYER, D
    [J]. VETERINARY RECORD, 1976, 98 (02) : 37 - 37
  • [8] Cytokines as adjuvants for avian vaccines
    Asif, M
    Jenkins, KA
    Hilton, LS
    Kimpton, WG
    Bean, AGD
    Lowenthal, JW
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (06): : 638 - 643
  • [9] Cytokines as adjuvants for ruminant vaccines
    Lofthouse, SA
    Andrews, AE
    Elhay, MJ
    Bowles, VM
    Meeusen, ENT
    Nash, AD
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1996, 26 (8-9) : 835 - 842
  • [10] Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases
    Lin, R
    Tarr, PE
    Jones, TC
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (06) : 1439 - 1449